Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Recursion Pharmaceuticals Inc Cl A (RXRX)

Recursion Pharmaceuticals Inc Cl A (RXRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
6.17 -0.36 (-5.51%) 03/26/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 6.12 -0.05 (-0.81%) 19:59 ET
Quote Overview for Wed, Mar 26th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
6.08
Day High
6.54
Open 6.52
Previous Close 6.53 6.53
Volume 15,109,199 15,109,199
Avg Vol 19,593,176 19,593,176
Stochastic %K 63.36% 63.36%
Weighted Alpha -52.17 -52.17
5-Day Change -0.41 (-6.23%) -0.41 (-6.23%)
52-Week Range 5.60 - 12.36 5.60 - 12.36
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,625,001
  • Shares Outstanding, K 401,991
  • Annual Sales, $ 58,840 K
  • Annual Income, $ -463,660 K
  • EBIT $ -479 M
  • EBITDA $ -443 M
  • 60-Month Beta 0.85
  • Price/Sales 46.39
  • Price/Cash Flow N/A
  • Price/Book 2.60

Options Overview Details

View History
  • Implied Volatility 76.28% ( +0.24%)
  • Historical Volatility 107.67%
  • IV Percentile 14%
  • IV Rank 6.01%
  • IV High 206.11% on 11/29/24
  • IV Low 67.98% on 09/24/24
  • Put/Call Vol Ratio 0.44
  • Today's Volume 12,229
  • Volume Avg (30-Day) 17,725
  • Put/Call OI Ratio 0.27
  • Today's Open Interest 232,912
  • Open Int (30-Day) 286,685

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.44
  • Number of Estimates 2
  • High Estimate -0.39
  • Low Estimate -0.48
  • Prior Year -0.39
  • Growth Rate Est. (year over year) -12.82%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.73 +7.68%
on 03/11/25
Period Open: 8.34
8.59 -28.17%
on 02/27/25
-2.17 (-26.02%)
since 02/26/25
3-Month
5.73 +7.68%
on 03/11/25
Period Open: 7.66
12.36 -50.08%
on 02/18/25
-1.49 (-19.45%)
since 12/26/24
52-Week
5.60 +10.18%
on 11/22/24
Period Open: 10.32
12.36 -50.08%
on 02/18/25
-4.15 (-40.21%)
since 03/26/24

Most Recent Stories

More News
2 Small-Cap Stocks Set to Skyrocket With Upside Potential Between 36% and 102%

These smaller stocks may carry more risk, but they also carry greater reward potential.

NVDA : 113.76 (-5.74%)
BAYRY : 6.1200 (-3.47%)
RXRX : 6.17 (-5.51%)
ARDX : 5.04 (-2.89%)
RHHBY : 42.6300 (-1.73%)
SNY : 54.50 (-1.71%)
Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun

RXRX : 6.17 (-5.51%)
Why Recursion Pharmaceuticals Stock Is Sinking Today

Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) were sinking 8.2% lower as of 10:57 a.m. ET on Monday. The clinical-stage biotech company, which is a pioneer in using artificial intelligence (AI) in...

RXRX : 6.17 (-5.51%)
Is This Beaten-Down Artificial Intelligence (AI) Stock a Buy?

The artificial intelligence (AI) industry has been on a tear in the past two years, and judging by analyst estimates, it's just the beginning. AI-related sales will continue to soar in the coming years,...

RXRX : 6.17 (-5.51%)
4 Things You Need to Know if You Buy Recursion Pharmaceuticals Stock Today

Investors looking for an exciting clinical-stage biotech start-up with enormous potential should be paying close attention to Recursion Pharmaceuticals (NASDAQ: RXRX) .

RXRX : 6.17 (-5.51%)
This Biotech Stock Could Be the Best Investment of the Decade

The term "game-changing" is overused for too many up-and-coming companies, but in this case, the description fits.

RXRX : 6.17 (-5.51%)
Down Over 40%, Is Recursion Pharmaceuticals a Buy on the Dip?

Machine-learning techniques keep improving efficiency in one industry after another. One corner of the economy where investors expect another big leap forward is the world of drug development.

RXRX : 6.17 (-5.51%)
Company News for Mar 3, 2025

The AES Corp.’s (AES) shares jumped 11.7% after the company reported fourth-quarter 2024 adjusted earnings per share of $0.54, surpassing the Zacks Consensus Estimate of $0.34.Shares of Recursion Pharmaceuticals...

PAR : 62.27 (-1.94%)
MOS : 27.12 (-0.22%)
RXRX : 6.17 (-5.51%)
AES : 12.49 (-1.34%)
Recursion Pharma Gets A Price-Target Cut After Q4 Miss: Retail Bearish Even As Cathie Wood's Ark Buys The Dip

Leerink cited concerns over high cash burn and execution risks in deal-making and clinical development over the next year.

NVDA : 113.76 (-5.74%)
RXRX : 6.17 (-5.51%)
SFTBY : 26.6900 (-2.63%)
Recursion Pharmaceuticals: Q4 Earnings Snapshot

Recursion Pharmaceuticals: Q4 Earnings Snapshot

RXRX : 6.17 (-5.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Recursion Pharmaceuticals Inc. is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering. Recursion Pharmaceuticals Inc. is based in SALT LAKE CITY.

See More

Key Turning Points

3rd Resistance Point 6.91
2nd Resistance Point 6.72
1st Resistance Point 6.45
Last Price 6.17
1st Support Level 5.99
2nd Support Level 5.80
3rd Support Level 5.53

See More

52-Week High 12.36
Fibonacci 61.8% 9.78
Fibonacci 50% 8.98
Fibonacci 38.2% 8.18
Last Price 6.17
52-Week Low 5.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies